EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Solitary Plasmacytomas: Current Status in 2025

Uğur Hatipoğlu, Mert Seyhan iD, Turgay Ulas iD, Mehmet Sinan Dal, Fevzi Altuntaş

Hematology Reports · 30.06.2025 · 17 (4) · 32

DOI: 10.3390/hematolrep17040032 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Hematology Reports, online erschienen am 30.06.2025. Verfasst von Uğur Hatipoğlu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology & Apheresis Unit, Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara 06170, Türkiye. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Solitary plasmacytoma refers to a neoplastic, clonal proliferation of plasma cells forming a single mass. They are divided based on their origin site; solitary bone plasmacytomas originate from the bones, and extramedullary plasmacytomas represent extraosseous tumors. These are rare tumors but carry a risk of transforming to multiple myeloma; thus, optimal management and meticulous follow-up are needed. Their rarity poses a major challenge in conducting large-scale clinical trials, leaving important gaps in evidence regarding best practices. Newer imaging techniques have improved the quality of staging, management decisions, and outcomes. Radiation still has a significant role in treatment algorithms, and adjuvant chemotherapy is gaining more importance; trials are underway in this area. Follow-up should contain biochemical tests as the proposed response definition criteria. We aimed to review the key studies and guidelines in this paper.

Schlagwörter

Stichwörter der Autor:innen

boneextramedullarymultiple myelomaplasma cell tumorplasmacytoma

Autor:innen und Institutionen

  • Department of Hematology & Apheresis Unit, Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara 06170, Türkiye.

ORCID-Profile: Mert Seyhan, Turgay Ulas

Zitieren

APA

Hatipoğlu, U., Seyhan, M., Ulas, T., Dal, M. S., & Altuntaş, F. (2025). Solitary Plasmacytomas: Current Status in 2025. Hematology Reports, 17(4), 32. https://doi.org/10.3390/hematolrep17040032

Vancouver

Hatipoğlu U, Seyhan M, Ulas T, Dal MS, Altuntaş F. Solitary Plasmacytomas: Current Status in 2025. Hematology Reports. 2025;17(4):32. doi:10.3390/hematolrep17040032

BibTeX
@article{Hatipolu2025,
  author = {Hatipoğlu, Uğur and Seyhan, Mert and Ulas, Turgay and Dal, Mehmet Sinan and Altuntaş, Fevzi},
  title = {Solitary Plasmacytomas: Current Status in 2025},
  journal = {Hematology Reports},
  year = {2025},
  volume = {17},
  number = {4},
  pages = {32},
  doi = {10.3390/hematolrep17040032}
}
Kostenlos starten →